Concepedia

Stephanie Curry

SC

24

Publications

822

Citations

17

H-Index

2003

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

United States Military Academy

Southern Research Institute

Institute of Virology of the Slovak Academy of Sciences

Stephanie Curry is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryVirologyImmunologyMedicinal ChemistryHepatitisDrug ResistanceNatural SciencesViral Hepatitis

Publications per year

2003–2018

24

Publications

24

Regulation of Eotaxin Gene Expression by TNF-α and IL-4 Through mRNA Stabilization: Involvement of the RNA-Binding Protein HuR

Ulus Atasoy, Stephanie Curry, Isabel López de Silanes et al. · The Journal of Immunology · 2003 · 119 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Molecular Regulation +25

Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir

Rong Liu, Stephanie Curry, Patricia McMonagle et al. · Antimicrobial Agents and Chemotherapy · 2015 · 76 citations · Full text

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons

Frederick Lahser, Karin Bystol, Stephanie Curry et al. · Antimicrobial Agents and Chemotherapy · 2016 · 57 citations · Full text

Hcv Ns5a Inhibitor, Genetics, Immunology +17

Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3

Marcelo Silva, Michelle Treitel, Donald J. Graham et al. · Journal of Hepatology · 2013 · 56 citations · Full text

Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells

Lisa A. Beck, B. Tancowny, Mary Brummet et al. · The Journal of Immunology · 2006 · 53 citations · Full text

Rows per page

1–5 of 24